Tumor Microenvironment Surveillance on Simultaneous Liver Metastases Extensive Stage Small Cell Lung Cancer

Hunan Province Tumor Hospital

Status: Completed

Conditions: Extensive Stage Small Cell Lung Cancer

Treatments: Drug: First line EC/EP+Atezolizumab

Study type: Observational

Funder types: Other

Identifiers

NCT05055999

MATCH

Details and patient eligibility

About

The purpose of the trial is to detect tumor microenvironment on Extensive Stage Small Cell Lung Cancer with simultaneous liver metastases who Treated with Atezolizumab plus Etoposide and Platinum Based Chemotherapy.

Enrollment: 60 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 18， Extensive Stage Small Cell Lung Cancer Confirmed by Histopathology Treated with Atezolizumab plus Etoposide and Platinum Based Chemotherapy

Exclusion criteria

• Patients with contraindication of chemotherapy Pregnant or breast feeding women